InsidersTradesSigma
Follow the ME Therapeutics Holdings Inc. stock price and the full insider trade history of the company, a publicly traded company based in Canada. Shares are listed on CA CA, under the oversight of SEDI. Market capitalisation: €25.8m. The latest transaction was filed on 11 July 2026 (52 - Expiration of options). Among the most active insiders: Nanji, Karim Haiderali. All data is openly available.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
7 of 7 declarations
ME Therapeutics Holdings Inc. is a company listed on the Toronto Stock Exchange, specializing in the development of innovative therapies. It focuses on enhancing medical treatments through biotechnology-based approaches.